PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with depression and suicidal thoughts- especially when anti-depressants and talk ...

Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without having to be on another type of antidepressant ...

Success starts in the trenches, and the Sun Devils’ turnaround along the offensive line was a major factor in their success in 2024. With four starters back for 2025, the line looks to once ...

The Colton School District says damage was done to their youth fields last week after someone drove their car onto the fields in the snow. More than 1,000 protestors took to the streets in ...

An estimated 21 million American adults suffer from clinical depression. © 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes ...

And now there’s a new option for treatment: Spravato, a nasal spray that’s been shown to give rapid relief to depression symptoms, was just approved as a stand-alone therapy by the Food and ...

“We have not seen that.” Research also suggests that esketamine nasal spray doesn’t affect thinking skills the way high doses of ketamine do. What’s Next Along with treatment-resistant ...

Now, the new FDA approval means that patients will be able use the ketamine-derived nasal spray, which is marketed under the brand name Spravato, without having to be on another type of ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression. According to reports, the FDA approved ...

Esketamine, a derivative of ketamine, is a rapid-acting antidepressant ... The expanded use of esketamine nasal spray as monotherapy is based on a randomized, double-blind, placebo-controlled ...